CXCR4 Blocker Shows Promise for Early COPD Treatment in Preclinical Study
Targeting CXCR4 protein improved lung function and reduced heart damage in early COPD mouse models, suggesting new therapeutic approach.
3494 articles
Targeting CXCR4 protein improved lung function and reduced heart damage in early COPD mouse models, suggesting new therapeutic approach.
New study shows combining PET scans with blood DNA tests can identify follicular lymphoma patients at high risk of early relapse.
New study reveals mitochondrial NAD+ concentration, not total cellular levels, determines how fast the liver can regenerate after injury.
Comprehensive review reveals emerging clinical evidence for NAD+ precursors in treating age-related diseases and cognitive decline.
New research reveals how a key RNA processing protein helps immune cells mature properly to fight artery plaque buildup.
Review reveals progress in using stem cell-derived heart cells to treat heart failure, but survival and safety hurdles remain.
Japanese trial shows dual HER2 blockade with pertuzumab plus trastuzumab improves overall survival even after prior pertuzumab treatment.
Real-world study of 664 patients reveals effective treatment options after T-DXd discontinuation, with low lung disease recurrence rates.
New research reveals how blood vessel dysfunction leads to dangerous aortic aneurysms through immune cell activation.
DNA methylation patterns reveal that patients with faster biological aging experience more rapid vision loss from glaucoma.
Large study reveals cancer survivors have higher biological age than cancer-free individuals, with strongest mortality predictions from epigenetic clocks.
Study of 1,014 adults finds GrimAge epigenetic clock most accurately links biological aging to physical performance from age 20-104.